Is a complete NEUP research report available?

No complete published report is available for Neuphoria Therapeutics Inc. (NEUP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · USD

$3.92

+0.12 (+3.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NEUP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	21.2M
Revenue (ttm)	-13.3K
Net income (ttm)	-17.4M
EPS (ttm)	-$4.95
Shares out	5.4M
Volume	71,155

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): -13.3K
Net income (ttm): -17.4M
EPS (ttm): -$4.95
Market cap: 21.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NEUP indicators

Market & fundamental data

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001191070
Company name	Neuphoria Therapeutics Inc.
Country	United States
Country code	US
Cusip	64136E102
Employees	8
Employees Change	0%
Employees Change Percent	0
Enterprise value	$1.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US64136E1029
Last refreshed	2026-07-31
Market cap	$21.2M
Market cap category	Nano-Cap
Price	$3.92
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	NEUP
Website	https://www.neuphoriatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-81.65%
FCF yield	-80.34%
P/B ratio	0.72x
P/S ratio	-1,609.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	126,329.97%
EBITDA Margin	121,333.35%
Gross Profit	$-13,267
Net Income	$-17.4M
Net Income Growth Years	3%
Pretax Margin	134,183.42%
Profit Per Employee	$-2.2M
ROA	-27.97
Roa5y	-22.34
ROCE	-50.34
ROE	-62.9
Roe5y	-44.47
ROIC	-166.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-54.23%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$34.8M
Cash	$19.4M
Current Assets	$21.7M
Current Liabilities	$1.5M
Debt	$34,225
Debt Equity	$0
Equity	$29.4M
Liabilities	$5.4M
Long Term Assets	$13.2M
Long Term Liabilities	$3.9M
Net Cash	$19.4M
Net Cash By Market Cap	$90.91
Net Cash Growth	15.02%
Net Debt Equity	$-0.66
Tangible Book Value	$16.3M
Tangible Book Value Per Share	$3.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.31
Net Working Capital	$738,169
Quick ratio	13.91
Working Capital	$20.1M
Working Capital Turnover	$-0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-161.08%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-54.21%
200-day SMA	4.73
50-day SMA	4.24
50-day SMA vs 200-day SMA	50under200
All Time High	21.4
All Time High Change	-81.68%
All Time High Date	2025-10-07
All Time Low	2.9
All Time Low Change	35.17%
All Time Low Date	2025-01-02
ATR	0.3
Beta1y	0.17
Beta2y	0.14
Ch YTD	1.03
High	4.06
High52	21.4
High52 Date	2025-10-07
High52ch	-81.68%
Low	3.73
Low52	3.19
Low52 Date	2026-07-01
Low52ch	22.88%
Ma50ch	-7.46%
Premarket Change Percent	-1.31
Premarket Price	$3.75
Premarket Volume	2,322
Price vs 200-day SMA	-17.04%
RSI	52.71
RSI Monthly	50.58
RSI Weekly	43.26
Sharpe ratio	0.13x
Sortino ratio	0.23
Total Return	-161.08%
Tr YTD	1.03
Tr1m	-10.91%
Tr3m	-24.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.56
Operating Income	$-14.7M
Operating margin	110,513.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,186,671%
Float Percent	77.47%
Shares Insiders	3.41%
Shares Institutions	38.14%
Shares Out	5,404,551
Shares Qo Q	19.29%
Shares Yo Y	161.08%
Short Float	0.37%
Short Ratio	0.16
Short Shares	0.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.5M
Adjusted OCF	-17,525,532
Average Volume	458,670.65x
Bv Per Share	5.47
Ch1m	-10.91
Ch1y	-54.21
Ch3m	-24.47
Ch6m	-2.49
Change	3.16%
Change From Open	3.16
Close	3.8
Days Gap	0
Depreciation Amortization	662,901
Dollar Volume	278,927.6
Earnings Date	2026-05-15
Earnings Time	bmo
EBIT	$-16.8M
EBITDA	$-16.1M
EPS	$-4.95
F Score	2
FCF	$-17.2M
FCF EV Yield	-883.42x
FCF Per Share	$-3.17
Financing CF	18,620,558
Fiscal Year End	June
Founded	1,996
Goodwill	8,843,549
Income Tax	$-370,982
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2025-09-29
Ma150	4.36
Ma150ch	-10.15%
Ma20	3.57
Ma20ch	9.77%
Net CF	2,321,173
Next Earnings Date	2026-09-28
Open	3.8
Optionable	No
Position In Range	57.58
Post Close	3.92
Postmarket Change Percent	-0.26
Postmarket Price	$3.91
Pre Close	3.8
Price Date	2026-07-30
Ptbv Ratio	1.31
Relative Volume	0.16x
Revenue	-13,267x
SBC By Revenue	-2,815.49x
Share Based Comp	373,531
Tr6m	-2.49%
Us State	Massachusetts
Volume	71,155
Z Score	-6.15

Neuphoria Therapeutics Inc. (NEUP)

Coverage state: Market snapshot only — no published research

Generate the first NEUP analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NEUP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NEUP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NEUP

Frequently asked questions